The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Open accessAbstract
Pancreatic cancer is a highly lethal malignancy with few effective therapies. We performed exome sequencing and copy number analysis to define genomic aberrations in a prospectively accrued clinical cohort (n = 142) of early (stage I and II) sporadic pancreatic ductal adenocarcinoma. Detailed analysis of 99 informative tumours identified substantial heterogeneity with 2,016 non-silent mutations and 1,628 copy-number variations. We define 16 significantly mutated genes, reaffirming known mutations (KRAS, TP53, CDKN2A, SMAD4, MLL3, TGFBR2, ARID1A and SF3B1), and uncover novel mutated genes including additional genes involved in chromatin modification (EPC1 and ARID2), DNA damage repair (ATM) and other mechanisms (ZIM2, MAP2K4, NALCN, SLC16A4 and MAGEA6). Integrative analysis with in vitro functional data and animal models provided supportive evidence for potential roles for these genetic aberrations in carcinogenesis. Pathway-based analysis of recurrently mutated genes recapitulated clustering in core signalling pathways in pancreatic ductal adenocarcinoma, and identified new mutated genes in each pathway. We also identified frequent and diverse somatic aberrations in genes described traditionally as embryonic regulators of axon guidance, particularly SLIT/ROBO signalling, which was also evident in murine Sleeping Beauty transposon-mediated somatic mutagenesis models of pancreatic cancer, providing further supportive evidence for the potential involvement of axon guidance genes in pancreatic carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among the identified genomic alterations (GAs) in PDAC, oncogenic KRAS mutations are the most common, occurring in close to 90% of patients, followed by TP53, CDKN2A, and SMAD47,8.”
From Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma (2024) · cites this paper as [7]
In the citing paper
“Amongst these are four canonical mutations – KRAS (~85%), TP53 (60–70%), CDKN2A (>50%), and SMAD4 (~50%).”
From KRAS mutation in pancreatic cancer (2021) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Trastuzumab-Induced Hepatotoxicity: A Case Report
Vucicevic, D., Carey, E. J., & Karlin, N. J. (2013) · Breast Care · doi:10.1159/000346844 · Cited by 4,432
Brocken, P., van der Heijden, E. H. F. M., Dekhuijzen, P. N. R., Peters-Bax, L., & de Geus‐Oei, L. (2013) · Respiration · doi:10.1159/000347096 · Cited by 4,011
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Self-citationMermel, C. H., Schumacher, S. E., Hill, B., Meyerson, M. M., Beroukhim, R., & Getz, G. A. (2011) · Genome biology · doi:10.1186/gb-2011-12-4-r41 · Cited by 3,520
International network of cancer genome projects
The International Cancer Genome Consortium (2010) · Nature · doi:10.1038/nature08987 · Cited by 2,299
Self-citationNeoptolemos, J. P., Stocken, D. D., Bassi, C., Ghaneh, P., Cunningham, D., Goldstein, D., Padbury, R., Moore, M. J., Gallinger, S., Mariette, C., et al. (2010) · JAMA · doi:10.1001/jama.2010.1275 · Cited by 1,395
Self-citationThe patterns and dynamics of genomic instability in metastatic pancreatic cancer
Campbell, P. J., Yachida, S., Mudie, L. J., Stephens, P. J., Pleasance, E. D., Stebbings, L. A., Morsberger, L. A., Latimer, C., McLaren, S., Lin, M.-L., et al. (2010) · Nature · doi:10.1038/nature09460 · Cited by 1,317
Self-citationExome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
Varela, I., Tarpey, P. S., Raine, K. M., Huang, D., Ong, C. K., Stephens, P., Davies, H. R., Jones, D., Lin, M., Teague, J. W., et al. (2011) · Nature · doi:10.1038/nature09639 · Cited by 1,302
Self-citation
Cited by
Sorted by citations
Items 301–400 of 1,002
Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision Medicine
Knudsen, E. S., O'Reilly, E. M., Brody, J. R., & Witkiewicz, A. K. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.056 · Cited by 115
Cancer whole-genome sequencing: present and future
Nakagawa, H., Wardell, C. P., Furuta, M., Taniguchi, H., & Fujimoto, A. (2015) · Oncogene · doi:10.1038/onc.2015.90 · Cited by 111
Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9
Ballehaninna, U. K., & Chamberlain, R. S. (2013) · Tumor Biology · doi:10.1007/s13277-013-1033-3 · Cited by 109
Finci, L. I., Zhang, X., Huang, X., Zhou, Q., Tsai, J., Teng, T., Agrawal, A. A., Chan, B., Irwin, S., Karr, C. D., et al. (2018) · Genes & Development · doi:10.1101/gad.311043.117 · Cited by 108
Baştürk, O., Tan, M. C. B., Bhanot, U. K., Allen, P. J., Adsay, V. N., Scott, S. N., Shah, R. H., Berger, M. F., Askan, G., Dikoglu, E., et al. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.98 · Cited by 108
Self-citationState of the art and future directions of pancreatic ductal adenocarcinoma therapy
Neuzillet, C., Tijeras‐Raballand, A., Bourget, P., Cros, J. F., Couvelard, A., Sauvanet, A., Vullierme, M., Tournigand, C., & Hammel, P. R. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.08.006 · Cited by 114
A reversible gene trap collection empowers haploid genetics in human cells
Bürckstümmer, T., Banning, C., Hainzl, P., Schobesberger, R., Kerzendorfer, C., Pauler, F. M., Chen, D., Them, N. C. C., Schischlik, F., Rebsamen, M., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2609 · Cited by 106
Wei, X., Yang, J., Adair, S. J., Öztürk, H., Kuscu, C., Lee, K. Y., Kane, W. J., O’Hara, P. E., Liu, D., Demirlenk, Y. M., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2009899117 · Cited by 109
Guillot, J., Dominici, C., Lucchesi, A., Nguyen, H., Puget, A., Hocine, M., Rangel‐Sosa, M. M., Simic, M., Nigri, J., Guillaumond, F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29659-w · Cited by 114
Preclinical models of pancreatic ductal adenocarcinoma
Hwang, C., Boj, S. F., Clevers, H. C., & Tuveson, D. A. (2015) · The Journal of Pathology · doi:10.1002/path.4651 · Cited by 105
Self-citationIntergenically Spliced Chimeric RNAs in Cancer
Jia, Y., Xie, Z., & Li, H. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.07.006 · Cited by 104
Wu, D., Wen, X., Han, X., Wang, S., Wang, Y., Shen, M., Fan, S., Zhang, Z.-F., Shan, Q., Li, M., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.02.022 · Cited by 105
RetractedLi, N., Yang, G., Luo, L., Li, L., Wang, X., Shi, L., Lan, J., Jia, X., Zhang, Q., Long, Z., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0674 · Cited by 106
Dal Molin, M., Zhang, M., de Wilde, R. F., Ottenhof, N. A., Rezaee, N., Wolfgang, C. L., Blackford, A., Vogelstein, B., Kinzler, K. W., Papadopoulos, N., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2600 · Cited by 101
Self-citationmicroRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis
Frampton, A. E., Krell, J., Jamieson, N. B., Gall, T., Giovannetti, E., Funel, N., Prado, M. M., Krell, D., Habib, N., Castellano, L., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.04.006 · Cited by 106
Dawkins, J. B. N., Wang, J., Maniati, E., Heward, J. A., Koniali, L., Kocher, H. M., Martin, S. A., Chelala, C., Balkwill, F. R., Fitzgibbon, J., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0481 · Cited by 104
Cui, L., Nakano, K., Obchoei, S., Setoguchi, K., Matsumoto, M., Yamamoto, T., Obika, S., Shimada, K., & Hiraoka, N. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.03.050 · Cited by 103
Youns, M., & Hegazy, W. A. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169335 · Cited by 103
A quarter century of EUS-FNA: Progress, milestones, and future directions
Bhutani, M., Cazacu, I. M., Chavez, A. L., Săftoiu, A., & Vilmann, P. (2018) · Endoscopic Ultrasound · doi:10.4103/eus.eus_19_18 · Cited by 104
Pishvaian, M. J., Blais, E. M., Brody, J. R., Rahib, L., Lyons, E. E., Arbeloa, P., Hendifar, A. E., Mikhail, S., Chung, V. M., Sohal, D. P. S., et al. (2019) · JCO Precision Oncology · doi:10.1200/po.19.00115 · Cited by 105
The acinar regulator Gata6 suppresses Kras G12V -driven pancreatic tumorigenesis in mice
Martinelli, P., Madriles, F., Cañamero, M., Pau, E. C. D. S., del Pozo, N., Guerra, C. E., & Real, F. X. (2015) · Gut · doi:10.1136/gutjnl-2014-308042 · Cited by 102
PTEN regulates RPA1 and protects DNA replication forks
Wang, G., Li, Y., Wang, P., Liang, H., Cui, M., Zhu, M., Guo, L., Su, Q. P., Sun, Y., McNutt, M. A., et al. (2015) · Cell Research · doi:10.1038/cr.2015.115 · Cited by 100
Tumor Heterogeneity in Pancreatic Adenocarcinoma
Cros, J. F., Raffenne, J., Couvelard, A., & Poté, N. (2017) · Pathobiology · doi:10.1159/000477773 · Cited by 106
Pancreatic cancer: Current research and future directions
Falasca, M., Kim, M., & Casari, I. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.01.001 · Cited by 101
Knudsen, E. S., Balaji, U., Mannakee, B. K., Vail, P. J., Eslinger, C. R., Moxom, C., Mansour, J. C., & Witkiewicz, A. K. (2017) · Gut · doi:10.1136/gutjnl-2016-313133 · Cited by 101
Ruivo, C. F., Bastos, N., Adem, B., Batista, I. A., Durães, C., Melo, C. A., Castaldo, S. A., Campos-Laborie, F. J., Moutinho-Ribeiro, P., Morão, B., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-324994 · Cited by 102
Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer
Mishra, N. K., & Guda, C. (2017) · Oncotarget · doi:10.18632/oncotarget.15993 · Cited by 99
Sinkala, M., Mulder, N., & Martin, D. P. (2020) · Scientific Reports · doi:10.1038/s41598-020-58290-2 · Cited by 100
WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies
Aldaz, C. M., Ferguson, B. W., & Abba, M. C. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.06.001 · Cited by 100
The biological function and clinical significance of SF3B1 mutations in cancer
Zhou, Z., Gong, Q., Wang, Y., Li, M., Wang, L., Ding, H., & Li, P. (2020) · Biomarker Research · doi:10.1186/s40364-020-00220-5 · Cited by 109
USP21 deubiquitinase promotes pancreas cancer cell stemness via Wnt pathway activation
Hou, P., Ma, X., Zhang, Q., Wu, C.-J., Liao, W., Li, J., Wang, H., Zhao, J., Zhou, X., Guan, C., et al. (2019) · Genes & Development · doi:10.1101/gad.326314.119 · Cited by 96
Stromal SLIT2 impacts on pancreatic cancer-associated neural remodeling
Secq, V., Leca, J., Bressy, C., Guillaumond, F., Skrobuk, P., Nigri, J., Lac, S., Lavaut, M.-N., Bui, T.-T., Thakur, A. K., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2014.557 · Cited by 98
Wang, Y., Li, Z., Zheng, S., Zhou, Y., Zhao, L., Ye, H., Zhao, X., Gao, W., Fu, Z., Zhou, Q., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5533 · Cited by 98
Boo, L., Ho, W. Y., Ali, N. M., Yeap, S. K., Kỳ, H., Chan, K., Yin, W. F., Satharasinghe, D. A., Liew, W. C., Tan, S. W., et al. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.12777 · Cited by 98
Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC)
Chandana, S. R., Babiker, H. M., & Mahadevan, D. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1557145 · Cited by 102
Gleeson, F. C., Kerr, S. E., Kipp, B. R., Voss, J. S., Minot, D. M., Tu, Z. J., Henry, M. R., Graham, R. P., Vasmatzis, G., Cheville, J. C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9440 · Cited by 97
Yu, S.-L., Xu, L.-T., Qi, Q., Geng, Y., Chen, H., Meng, Z.-Q., Wang, P., & Chen, Z. (2017) · Scientific Reports · doi:10.1038/srep45194 · Cited by 100
Extrinsic KRAS signaling shapes the pancreatic microenvironment through fibroblast reprogramming
Velez-Delgado, A., Donahue, K. L., Brown, K. L., Du, W., Irizarry-Negron, V., Menjivar, R. E., Lasse Opsahl, E. L., Steele, N. G., The, S., Lazarus, J., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.02.016 · Cited by 91
Liu, J., Du, X., Zhou, J., Pan, Z., Liu, H., & Li, Q. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.114.122788 · Cited by 96
Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine
Conway, J. R. W., Herrmann, D., Evans, T. J., Morton, J. P., & Timpson, P. (2018) · Gut · doi:10.1136/gutjnl-2018-316822 · Cited by 97
Chen, S., Chen, J.-Z., Zhang, J., Chen, H., Qiu, F., Yan, M.-L., Tian, Y., Peng, C., Shen, B., Chen, Y., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2018.12.017 · Cited by 96
Mishra, V. K., Wegwitz, F., Kosinsky, R. L., Sen, M., Baumgartner, R., Wulff, T., Siveke, J. T., Schildhaus, H., Najafova, Z., Kari, V., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx212 · Cited by 97
Leiphrakpam, P. D., Chowdhury, S., Zhang, M. H., Bajaj, V., Dhir, M., & Are, C. (2025) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-025-01183-2 · Cited by 99
Mechanisms of genome instability induced by RNA-processing defects
Chan, Y. A., Hieter, P., & Stirling, P. C. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.03.005 · Cited by 96
Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma
Yousef, A., Yousef, M., Chowdhury, S., Abdilleh, K., Knafl, M., Edelkamp, P., Alfaro-Munoz, K., Chacko, R., Peterson, J., Smaglo, B. G., et al. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00505-0 · Cited by 93
Self-citationRovithi, M. N., Avan, A., Funel, N., León, L. G., Gómez‐Mellado, V. E., Wurdinger, T. D., Griffioen, A. W., Verheul, H. M. W., & Giovannetti, E. (2017) · Scientific Reports · doi:10.1038/srep44686 · Cited by 93
Prognostic and predictive factors in pancreatic cancer
Dell’Aquila, E., Fulgenzi, C. A. M., Minelli, A., Citarella, F., Stellato, M., Pantano, F., Russano, M., Cursano, M. C., Napolitano, A., Zeppola, T., et al. (2020) · Oncotarget · doi:10.18632/oncotarget.27518 · Cited by 101
Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer
Riva, F., Dronov, O. I., Khomenko, D. I., Huguet, F., Louvet, C., Mariani, P., Stern, M., Lantz, O. J., Proudhon, C., Pierga, J., et al. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.01.006 · Cited by 97
Fei, D. L., Motowski, H., Chatrikhi, R., Prasad, S., Yu, J., Gao, S., Kielkopf, C. L., Bradley, R. K., & VARMUS, H. E. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006384 · Cited by 90
Murthy, D., Attri, K. S., & Singh, P. K. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00335 · Cited by 96
Genetics of familial and sporadic pancreatic cancer
Wood, L. D., Yurgelun, M. B., & Goggins, M. G. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.12.039 · Cited by 91
A RhoA-FRET Biosensor Mouse for Intravital Imaging in Normal Tissue Homeostasis and Disease Contexts
Nobis, M., Herrmann, D., Warren, S. C., Kadir, S. R., Leung, W., Killen, M. J., Magenau, A., Stevenson, D., Lucas, M. C., Reischmann, N., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.022 · Cited by 88
Self-citationPancreatic Ductal Adenocarcinoma and Its Precursor Lesions
Ren, B., Liu, X., & Suriawinata, A. A. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.10.004 · Cited by 99
Erami, Z., Herrmann, D., Warren, S. C., Nobis, M., McGhee, E. J., Lucas, M. C., Leung, W., Reischmann, N., Mrowinska, A., Schwarz, J. P., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.12.020 · Cited by 87
Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians
Spadi, R. (2016) · World Journal of Clinical Oncology · doi:10.5306/wjco.v7.i1.27 · Cited by 90
Pei, Y., Liang, C., Huang, Y., Wang, J., Feng, J., Xu, M., Chen, Y., Song, Q., Jiang, G., Gu, X. Q., et al. (2019) · Small · doi:10.1002/smll.201900631 · Cited by 91
Mechismo: predicting the mechanistic impact of mutations and modifications on molecular interactions
Betts, M. J., Lu, Q., Jiang, Y., Drusko, A., Wichmann, O., Utz, M., Valtierra-Gutiérrez, I. A., Schlesner, M., Jäger, N., Jones, D., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1094 · Cited by 90
RADIA: RNA and DNA Integrated Analysis for Somatic Mutation Detection
Radenbaugh, A., Ma, S., Ewing, A. D., Stuart, J. M., Collisson, E. A., Zhu, J., & Haussler, D. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111516 · Cited by 92
Glassman, D. C., Palmaira, R. L. D., Covington, C. M., Desai, A. M., Ku, G. Y., Li, J., Harding, J. J., Varghese, A. M., O'Reilly, E. M., & Yu, K. H. (2018) · BMC Cancer · doi:10.1186/s12885-018-4605-1 · Cited by 89
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer
Adams, C. R., Htwe, H. H., Marsh, T., Wang, A. L., Montoya, M., Subbaraj, L., Tward, A. D., Bardeesy, N. M., & Perera, R. M. (2019) · eLife · doi:10.7554/elife.45313 · Cited by 88
Burrack, A. L., Spartz, E. J., Raynor, J. F., Wang, I., Olson, M. A., & Stromnes, I. M. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.059 · Cited by 89
Alam, M. M., Lal, S., FitzGerald, K. E., & Li, Z. (2016) · Clinical and Translational Medicine · doi:10.1186/s40169-016-0082-9 · Cited by 92
Hayashi, H., Kohno, T., Ueno, H., Hiraoka, N., Kondo, S., Saito, M., Shimada, Y., Ichikawa, H., Kato, M., Shibata, T., et al. (2017) · Pancreas · doi:10.1097/mpa.0000000000000760 · Cited by 88
Large, T. Y. S. L., Bijlsma, M. F., Geert Kazemier, M., van Laarhoven, H. W. M., Giovannetti, E., & Jiménez, C. R. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.03.008 · Cited by 93
Wang, W., Friedland, S. C., Guo, B., O’Dell, M. R., Alexander, W. B., Whitney‐Miller, C. L., Agostini‐Vulaj, D., Huber, A. R., Myers, J. R., Ashton, J. M., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315541 · Cited by 96
Liquid biopsy for cancer: review and implications for the radiologist
Underwood, J. J., Quadri, R. S., Kalva, S. P., Shah, H., Sanjeeviah, A. R., Beg, M. S., & Sutphin, P. D. (2020) · Radiology · doi:10.1148/radiol.2019182584 · Cited by 87
Slit-Robo Repulsive Signaling Extrudes Tumorigenic Cells from Epithelia
Vaughen, J., & Igaki, T. (2016) · Developmental Cell · doi:10.1016/j.devcel.2016.11.015 · Cited by 79
Niu, N., Lu, P., Yang, Y.-L., He, R., Zhang, L., Shi, J., Wu, J., Yang, M., Zhang, Z., Wang, L., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318362 · Cited by 86
Self-citationMutations in spliceosome genes and therapeutic opportunities in myeloid malignancies
Taylor, J., & Lee, S. C.-W. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22784 · Cited by 88
Huang, W., Navarro-Serer, B., Jeong, Y. J., Chianchiano, P. E., Xia, L., Luchini, C., Veronese, N., Dowiak, C., Ng, T., Trujillo, M. A. M., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-1523 · Cited by 91
Self-citationEmerging mechanisms and promising approaches in pancreatic cancer metabolism
Wu, H., Fu, M., Wu, M., Cao, Z., Zhang, Q., & Liu, Z. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06930-0 · Cited by 97
Tian, T. V., Tomavo, N., Huot, L., Flourens, A., Bonnelye, E., Flajollet, S., Hot, D., Leroy, X., de Launoit, Y., & Duterque‐Coquillaud, M. (2013) · Oncogene · doi:10.1038/onc.2013.176 · Cited by 92
Survival Among Patients With Pancreatic Cancer and Long-Standing or Recent-Onset Diabetes Mellitus
Yuan, C., Rubinson, D. A., Qian, Z. R., Wu, C. H., Kraft, P. L., Bao, Y., Ogino, S., Ng, K., Clancy, T. E., Swanson, R. S., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.5688 · Cited by 87
Kim, H., Saka, B., Knight, S., Borges, M. W., Childs, E. J., Klein, A. P., Wolfgang, C. L., Herman, J. M., Adsay, V. N., Hruban, R. H., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1239 · Cited by 88
Self-citationPolvani, S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i8.2441 · Cited by 89
Li, C., Xiao, Z., TONG, J. H. M., To, K., Fang, X., Cheng, A. S. L., & Chen, Y. (2016) · International Journal of Cancer · doi:10.1002/ijc.30414 · Cited by 86
KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops
Eibl, G., & Rozengurt, E. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.10.007 · Cited by 88
Functional annotation of rare gene aberration drivers of pancreatic cancer
Tsang, Y. H., Dogruluk, T., Tedeschi, P. M., Wardwell‐Ozgo, J., Lu, H., Espitia, M., Nair, N. V., Minelli, R., Chong, Z., Chen, F., et al. (2016) · Nature Communications · doi:10.1038/ncomms10500 · Cited by 84
Self-citationKo, J., Bhagwat, N., Black, T. A., Yee, S. S., Na, Y.-J., Fisher, S., Kim, J., Carpenter, E. L., Stanger, B. Z., & Issadore, D. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3703 · Cited by 86
Keratin 17 identifies the most lethal molecular subtype of pancreatic cancer
Roa‐Peña, L., Leiton, C. V., Babu, S., Pan, C., Vanner, E. A., Akalin, A., Bandovic, J., Moffitt, R. A., Shroyer, K. R., & Escobar‐Hoyos, L. F. (2019) · Scientific Reports · doi:10.1038/s41598-019-47519-4 · Cited by 85
Schwann cells support oncogenic potential of pancreatic cancer cells through TGFβ signaling
Roger, É., Martel, S., Bertrand‐Chapel, A., Depollier, A., Chuvin, N., Pommier, R. M., Yacoub, K., Caligaris, C., Cardot‐Ruffino, V., Chauvet, V., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2116-x · Cited by 86
Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma
Neeße, A., Gress, T. M., Tuveson, D. A., Michl, P., & Krug, S. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s38111 · Cited by 87
Self-citationBijlsma, M. F., & van Laarhoven, H. W. M. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9541-1 · Cited by 84
MicroRNA-138-5p regulates pancreatic cancer cell growth through targeting FOXC1
Yu, C., Wang, M., Li, Z., Xiao, J., Peng, F., Guo, X., Deng, Y., Jiang, J., & Sun, C. (2015) · Cellular Oncology · doi:10.1007/s13402-014-0200-x · Cited by 84
Self-citationSOX9 regulates ERBB signalling in pancreatic cancer development
Grimont, A., Pinho, A. V., Cowley, M. J., Augereau, C., Mawson, A., Giry-Laterrière, M., Steen, G. V. D., Waddell, N., Pajic, M., Sempoux, C. L., et al. (2014) · Gut · doi:10.1136/gutjnl-2014-307075 · Cited by 84
Self-citationMatrix Metalloproteases in Pancreatic Ductal Adenocarcinoma: Key Drivers of Disease Progression?
Slapak, E. J., Duitman, J., Tekin, C., Bijlsma, M. F., & Spek, C. A. (2020) · Biology · doi:10.3390/biology9040080 · Cited by 84
Goldsmith, C., Vuong, Q. V., Sadeqzadeh, E., Stathopoulos, C. E., Roach, P. D., & Scarlett, C. J. (2015) · Molecules · doi:10.3390/molecules200712992 · Cited by 84
Self-citationYabar, C. S., & Winter, J. M. (2016) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.04.003 · Cited by 85
KRASmutations in blood circulating cell-free DNA: a pancreatic cancer case-control
Calvez‐Kelm, F. L., Foll, M., Wozniak, M. B., Delhomme, T. M., Durand, G., Chopard, P., Pertesi, M., Fabiánová, E., Adamčáková, Z. K., Holcátová, I., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12386 · Cited by 85
Genetic landscape of sporadic vestibular schwannoma
Håvik, A. L., Bruland, O., Myrseth, E., Miletić, H., Aarhus, M., Knappskog, P. M., & Lund‐Johansen, M. (2017) · Journal of neurosurgery · doi:10.3171/2016.10.jns161384 · Cited by 83
McIntyre, C. A., Grimont, A., Park, J., Meng, Y., Sisso, W. J., Seier, K. P., Jang, G. H., Walch, H. S., Aveson, V. G., Falvo, D. J., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.08.002 · Cited by 85
Therapeutic Effects of an Anti-Myc Drug on Mouse Pancreatic Cancer
Stellas, D., Szabolcs, M. J., Koul, S., Li, Z., Polyzos, A., Anagnostopoulos, C., Cournia, Z., Tamvakopoulos, C., Klinakis, A., & Efstratiadis, A. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju320 · Cited by 87
Paiella, S., Sandini, M., Gianotti, L. V., Butturini, G., Salvia, R., & Bassi, C. (2016) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2016.02.003 · Cited by 83
Re‐adapting T cells for cancer therapy: from mouse models to clinical trials
Stromnes, I. M., Schmitt, T. M., Chapuis, A. G., Hingorani, S. R., & Greenberg, P. D. (2013) · Immunological Reviews · doi:10.1111/imr.12141 · Cited by 82
The SWI/SNF genetic blockade: effects in cell differentiation, cancer and developmental diseases
Romero, O. A., & Sánchez‐Céspedes, M. (2013) · Oncogene · doi:10.1038/onc.2013.227 · Cited by 85
Eshleman, J. R., Norris, A. L., Sadakari, Y., Debeljak, M., Borges, M. W., Harrington, C. T., Lin, E. I., Brant, A., Barkley, T., Almario, J. A., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.11.028 · Cited by 82
Self-citationRole of CYB5A in Pancreatic Cancer Prognosis and Autophagy Modulation
Giovannetti, E., Wang, Q., Avan, A., Funel, N., Lagerweij, T., Lee, J., Caretti, V., van der Velde, A., Boggi, U., Wang, Y., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt346 · Cited by 82
Sugimori, M., Sugimori, K., Tsuchiya, H., Suzuki, Y., Tsuyuki, S., Kaneta, Y., Hirotani, A., Sanga, K., Tozuka, Y., Komiyama, S., et al. (2019) · Cancer Science · doi:10.1111/cas.14245 · Cited by 81
Structural and functional modularity of the U2 snRNP in pre-mRNA splicing
van der Feltz, C. L., & Hoskins, A. A. (2019) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2019.1691497 · Cited by 81
Implication of PI3K/Akt pathway in pancreatic cancer: When PI3K isoforms matter?
Baer, R., Cintas, C., Therville, N., & Guillermet‐Guibert, J. (2015) · Advances in Biological Regulation · doi:10.1016/j.jbior.2015.05.001 · Cited by 85
Metadata
- Authors
- Initiative, A. P. C. G., Biankin, A. V., Waddell, N., Kassahn, K. S., Gingras, M.-C., Muthuswamy, L. B., Johns, A. L., Miller, D. K., Wilson, P. J., Patch, A.-M., Wu, J., Chang, D. K., Cowley, M. J., Gardiner, B. B., Song, S., Harliwong, I., Idrisoglu, S., Nourse, C., Nourbakhsh, E., Manning, S., Wani, S., Gongora, M., Pajic, M., Scarlett, C. J., Gill, A. J., Pinho, A. V., Rooman, I., Anderson, M., Holmes, O., Leonard, C., Taylor, D., Wood, S., Xu, Q., Nones, K., Lynn Fink, J., Christ, A., Bruxner, T., Cloonan, N., Kolle, G., Newell, F., Pinese, M., Scott Mead, R., Humphris, J. L., Kaplan, W., Jones, M. D., Colvin, E. K., Nagrial, A. M., Humphrey, E. S., Chou, A., Chin, V. T., Chantrill, L. A., Mawson, A., Samra, J. S., Kench, J. G., Lovell, J. A., Daly, R. J., Merrett, N. D., Toon, C., Epari, K., Nguyen, N. Q., Barbour, A., Zeps, N., Kakkar, N., Zhao, F., Qing Wu, Y., Wang, M., Muzny, D. M., Fisher, W. E., Charles Brunicardi, F., Hodges, S. E., Reid, J. G., Drummond, J., Chang, K., Han, Y., Lewis, L. R., Dinh, H., Buhay, C. J., Beck, T., Timms, L., Sam, M., Begley, K., Brown, A., Pai, D., Panchal, A., Buchner, N., De Borja, R., Denroche, R. E., Yung, C. K., Serra, S., Onetto, N., Mukhopadhyay, D., Tsao, M.-S., Shaw, P. A., Petersen, G. M., Gallinger, S., Hruban, R. H., Maitra, A., Iacobuzio-Donahue, C. A., Schulick, R. D., Wolfgang, C. L., Morgan, R. A., Lawlor, R. T., Capelli, P., Corbo, V., Scardoni, M., Tortora, G., Tempero, M. A., Mann, K. M., Jenkins, N. A., Perez-Mancera, P. A., Adams, D. J., Largaespada, D. A., Wessels, L. F. A., Rust, A. G., Stein, L. D., Tuveson, D. A., Copeland, N. G., Musgrove, E. A., Scarpa, A., Eshleman, J. R., Hudson, T. J., Sutherland, R. L., Wheeler, D. A., Pearson, J. V., McPherson, J. D., Gibbs, R. A., & Grimmond, S. M.
- Affiliations
- Garvan Institute of Medical Research (AU)
- The University of Queensland (AU)
- Ontario Institute for Cancer Research (CA)
- The University of Sydney (AU)
- Royal Adelaide Hospital (AU)
- St John of God Subiaco Hospital (AU)
- Baylor College of Medicine (US)
- University of California, Los Angeles (US)
- University Health Network (CA)
- Johns Hopkins University (US)
- University of Verona (IT)
- Houston Methodist (US)
- University of Minnesota (US)
- Wellcome Sanger Institute (GB)
- Corresponding author
- Grimmond, Sean M.
- ORCID
- Biankin, Andrew V.
- Waddell, Nicola
- Kassahn, Karin S.
- Gingras, Marie-Claude
- Muthuswamy, Lakshmi B.
- Johns, Amber L.
- Wilson, Peter J.
- Patch, Ann-Marie
- Wu, Jianmin
- Chang, David K.
- Cowley, Mark J.
- Gardiner, Brooke B.
- Song, Sarah
- Harliwong, Ivon
- Nourbakhsh, Ehsan
- Manning, Suzanne
- Wani, Shivangi
- Pajic, Marina
- Scarlett, Christopher J.
- Gill, Anthony J.
- Pinho, Andreia V.
- Rooman, Ilse
- Anderson, Matthew
- Holmes, Oliver
- Leonard, Conrad
- Wood, Scott
- Christ, Angelika
- Cloonan, Nicole
- Newell, Felicity
- Pinese, Mark
- Kaplan, Warren
- Jones, Marc D.
- Colvin, Emily K.
- Nagrial, Adnan M.
- Chou, Angela
- Chin, Venessa T.
- Chantrill, Lorraine A.
- Mawson, Amanda
- Samra, Jaswinder S.
- Kench, James G.
- Daly, Roger J.
- Merrett, Neil D.
- Toon, Christopher
- Nguyen, Nam Q.
- Barbour, Andrew
- Zeps, Nikolajs
- Zhao, Fengmei
- Muzny, Donna M.
- Drummond, Jennifer
- Chang, Kyle
- Han, Yi
- Dinh, Huyen
- Beck, Timothy
- Begley, Kimberly
- Brown, Andrew
- Denroche, Robert E.
- Yung, Christina K.
- Serra, Stefano
- Mukhopadhyay, Debabrata
- Tsao, Ming-Sound
- Petersen, Gloria M.
- Hruban, Ralph H.
- Maitra, Anirban
- Schulick, Richard D.
- Wolfgang, Christopher L.
- Lawlor, Rita T.
- Corbo, Vincenzo
- Tortora, Giampaolo
- Tempero, Margaret A.
- Mann, Karen M.
- Jenkins, Nancy A.
- Adams, David J.
- Wessels, Lodewyk F. A.
- Rust, Alistair G.
- Stein, Lincoln D.
- Tuveson, David A.
- Scarpa, Aldo
- Eshleman, James R.
- Hudson, Thomas J.
- Wheeler, David A.
- Pearson, John V.
- McPherson, John D.
- Gibbs, Richard A.
- Grimmond, Sean M.
- Venue
- Nature
- Published
- 2012-10-24
- Volume
- 491
- Issue
- 7424
- Pages
- 399-405
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3530898
- OpenAlex
- W2161884651
- Cited by
- 2,058
- References
- 41
- Citations by year
- 2026: 62 · 2025: 98 · 2024: 90 · 2023: 128 · 2022: 173 · 2021: 190 · 2020: 168 · 2019: 163 · 2018: 159 · 2017: 187 · 2016: 191 · 2015: 176 · 2014: 157 · 2013: 113 · 2012: 1
- FWCI
- 70.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eSpace (Curtin University) (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- NOVA (University of Newcastle Australia) (submittedVersion)
- Funders
- American Association for Cancer Research
- Cancer Prevention and Research Institute of Texas (RP101353-P7, RP101353)
- Johns Hopkins University (P50CA062924)
- Royal College of Pathologists of Australasia
- Wellcome Trust
- Australian Government
- Cancer Research UK (13031)
- Australian Cancer Research Foundation
- Cancer Institute NSW
- Gastroenterological Society of Australia
- Royal Australasian College of Physicians
- Agency for Science, Technology and Research
- Petre Foundation
- Queensland Government
- R.T. Hall Trust
- Associazione Italiana per la Ricerca sul Cancro (12182, 5 x mille)
- Università degli Studi di Verona
- Ministero dello Sviluppo Economico
- National Institutes of Health (CA102701)
- Medical Research Council
- National Health and Medical Research Council (535914, 631701, 535903, 427601)
- Cancer Council NSW (SRP06-01)
- National Human Genome Research Institute (HG003273, U54HG003273)
- National Cancer Institute (CA102701, R01CA-97075, P01CA134292, P50CA101955, P50CA102701, R01CA113636, R01CA097075, P50CA062924)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- pancreatic ductal adenocarcinoma, axon guidance genes, somatic mutations, copy number variation, chromatin modification, DNA repair, ATM, carcinogenesis, pathway analysis, patient survival, Sleeping Beauty transposon mutagenesis, early-stage pancreatic cancer
- MeSH terms
- Animals, Axons, Humans, Mutation, Pancreatic Neoplasms, Proteins, Signal Transduction, Gene Expression Regulation, Neoplastic, Genome, Gene Dosage, Carcinoma, Pancreatic Ductal, Mice, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
